Lumentum Holdings slipped 0.6% in regular trading, a mild pullback for a stock that has eased over the past month, even as fresh Q1 2027 results landed with a jolt. The headline is simple. Revenue came in at US$1,262.6 million and basic earnings per share were US$3.90, a sharp swing back into profit after a heavy loss in Q4 2026.
The gap between that modest price move and the scale of the earnings reset is where attention is likely to focus. Traders are reacting to a single quarter. Multi-year holders are watching how the company manages the balance between high growth, a rich P/S ratio and recent dilution.
Love the sharp swing back to profit at Lumentum Holdings but concerned about dilution and a rich P/S ratio? Screen for companies that combine solid balance sheets with disciplined share counts in our list of solid balance sheet and fundamentals stocks (24 results).
Ask Charlie what Lumentum’s rich sales multiple is pricing in.
"The main requirement is that Lumentum Holdings continues to execute on its AI optics roadmap, including the ramp of optical circuit switching, ultra high power lasers for CPO and NPO, and new InP capacity such as the Greensboro fab."
Lumentum is checking several of those boxes. Q1 2027 revenue of US$1,262.6 million and profit of US$360.3 million arrive alongside fresh evidence of AI optics traction, including especially strong pump lasers and optical circuit switches and a second NPO or CPO contract with purchase commitments above US$5b. Guidance for Q2 2027 revenue of US$1.58b to US$1.63b and non GAAP EPS of US$5.90 to US$6.20 points to that roadmap already scaling rather than sitting on paper.
One Narrative disagrees with today's price. → See where this Narrative says Lumentum Holdings should trade.
Bears argue Lumentum could mis-time capacity and end up eroding profitability if supply outruns real AI demand.
"Management’s plan to quadruple pump laser output over the next several quarters and ramp multiple fabs through 2029 risks pushing this product set toward overcapacity once demand normalises, which could pressure pricing and future net margins."
Q1 2027 tells a different story so far. Revenue of US$1,262.6 million and profit of US$360.3 million arrive while capacity is still described as tight and supported by long term purchase commitments, including a second NPO or CPO contract above US$5b. The stress point is mix. Trailing 12 month losses of US$6.6b show that higher volume has not yet translated into consistently healthy net margins across the cycle.
Lumentum Holdings just showed how a sharp earnings reset does not always trigger a matching move in its share price. The real opportunity could sit in stocks that could be undervalued before the market closes that gap.
Those are three of them. See the full list of 34 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com